Hypercalcaemia ✅
Related Subjects:
| Familial Hypocalciuric Hypercalcaemia (FHH)
| Primary Hyperparathyroidism
| Lung Cancer
| Hypercalcaemia
| Multiple Myeloma
| Oncological Emergencies
| Bisphosphonates
🚑 Hypercalcaemia Emergency Management – Ward Algorithm
Hypercalcaemia severity (albumin-adjusted calcium):
- 🟢 Mild: 2.6–3.0 mmol/L
- 🟠 Moderate: 3.0–3.5 mmol/L
- 🔴 Severe: >3.5 mmol/L (medical emergency)
1️⃣ Immediate Clinical Assessment
- Perform ABCDE assessment. Assess hydration status and fluid balance.
- Check for neurological symptoms: Confusion, Lethargy, Delirium, Reduced GCS
- Look for dehydration signs: Dry mucous membranes, Tachycardia, Postural hypotension
- Record baseline observations and urine output.
- Perform ECG monitoring. Look for Short QT interval, Occasionally heart block or ventricular arrhythmias
2️⃣ Confirm the Diagnosis
- Check albumin-adjusted serum calcium.
- Repeat calcium if unexpected or borderline.
- Assess severity category to guide urgency of treatment.
3️⃣ First-Line Treatment – Volume Expansion
- 💧 Start IV 0.9% saline. Typical replacement: 2–4 litres within the first 24 hours
- Adjust according to age, renal function, and heart failure risk
- Aim to restore intravascular volume and promote renal calcium excretion.
- Monitor: Fluid balance, Urine output, Daily weights if needed
- Loop diuretics should NOT be used routinely but may be useful if fluid overload develops.
4️⃣ Investigate the Underlying Cause
🧪 The most important early branching test in hypercalcaemia is parathyroid hormone (PTH).
If PTH is high or inappropriately normal, think primary/tertiary hyperparathyroidism.
If PTH is suppressed, think malignancy, myeloma, vitamin D excess, granulomatous disease, drugs or other endocrine causes.
NICE NG132 says that to differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcaemia (FHH), measure urine calcium excretion using one of: 24-hour urinary calcium excretion, random renal calcium:creatinine excretion ratio, or random calcium:creatinine clearance ratio.
- 🧪 Confirm and assess severity:
- Repeat corrected calcium or ionised calcium if available
- Albumin, Urea & electrolytes, TFTs, eGFR, Phosphate, Magnesium, Glucose
- ECG if moderate/severe hypercalcaemia or cardiac symptoms
- PTH, Vitamin D ALP , FBC , ESR or CRP, LFTs
- Myeloma / malignancy screen: Serum protein electrophoresis and Serum free light chains. Urine Bence Jones protein / urine electrophoresis where used locally.
- Consider CXR, CT imaging or cancer-specific tests depending on symptoms and examination
💊 Medication and supplement review:
- Thiazide diuretics, Lithium, Calcium supplements
- Vitamin D or vitamin A excess
- Antacids / calcium carbonate preparations
🦴 If PTH is high or inappropriately normal:
- Consider primary hyperparathyroidism
- Consider tertiary hyperparathyroidism in advanced CKD
- Check urinary Ca excretion / calcium-creatinine clearance ratio if familial hypocalciuric hypercalcaemia is possible
- Consider bone density assessment, renal stones history and renal tract imaging depending on context
- Check PTHrP when hypercalcaemia looks PTH-independent, especially when malignancy is suspected.
🌫️ If PTH is suppressed:
- Consider malignancy, myeloma, bone metastases or PTHrP-mediated hypercalcaemia
- Consider granulomatous disease such as sarcoidosis or TB
- Consider thyrotoxicosis, adrenal insufficiency, immobilisation or vitamin D toxicity
- Additional tests may include PTHrP, 1,25-dihydroxyvitamin D, ACE level, TFTs, cortisol or imaging, guided by clinical suspicion
🫁 Imaging if malignancy suspected: Chest X-ray, CT scan where indicated
🧠 Teaching point: PTH should be suppressed when calcium is high. A “normal” PTH in hypercalcaemia is therefore abnormal, because it is inappropriately normal and suggests PTH-driven disease.
PTH interpretation:
- ⬆️ Calcium + ⬆️ or normal PTH → Primary hyperparathyroidism
- ⬆️ Calcium + ⬇️ PTH → Malignancy, vitamin D excess, granulomatous disease
5️⃣ Second-Line Treatment – Anti-resorptive Therapy
- 💉 Give an IV bisphosphonate once the patient is adequately hydrated.
- Zoledronic acid 4 mg IV over ~15 minutes
- Pamidronate 60–90 mg IV over 2–4 hours
- Effects: Onset: 24–48 hours Peak calcium reduction: 4–7 days
- Use with caution in renal impairment.
6️⃣ Additional Therapies (Selected Cases)
- Calcitonin Produces rapid calcium reduction. Effect begins within hours. Short-lived (tachyphylaxis occurs)
- Glucocorticoids: Useful in: Sarcoidosis, Lymphoma, Vitamin D intoxication
- Denosumab: Used in bisphosphonate-resistant malignancy-associated hypercalcaemia. Also useful in severe renal impairment
7️⃣ Management of Severe or Refractory Hypercalcaemia
- Consider dialysis if: Severe hypercalcaemia (>3.5–4 mmol/L), Renal failure, Fluid overload preventing hydration
- Seek urgent specialist input: Endocrinology, Oncology, Renal team
8️⃣ Definitive Treatment
- Management ultimately depends on the underlying cause.
- Common treatments include:
- Parathyroidectomy for primary hyperparathyroidism
- Oncological therapy for malignancy
- Steroids for granulomatous disease
- Stopping causative drugs (e.g. thiazides, vitamin D excess)
🚑 Hypercalcaemia Emergency Algorithm (Ward Management)
| Step |
Action |
Clinical Notes |
| 1️⃣ Confirm Hypercalcaemia |
- Check albumin-adjusted calcium
- Repeat sample to confirm
- Assess severity
|
- Mild: 2.6–3.0 mmol/L
- Moderate: 3.0–3.5 mmol/L
- Severe: >3.5 mmol/L
|
| 2️⃣ Assess Patient |
- ABCDE assessment
- Hydration status
- Neurological symptoms
- ECG monitoring
|
Look for:
- Confusion
- Dehydration
- Polyuria
- Short QT on ECG
|
| 3️⃣ Initial Treatment |
- 💧 IV 0.9% saline
- Typical rate: 2–4 L in first 24 h
- Adjust for elderly or heart failure
|
Hydration restores renal calcium excretion and is the first-line treatment.
|
| 4️⃣ Identify Cause |
- PTH
- U&Es
- Phosphate
- Vitamin D
- Myeloma screen
- CXR / imaging if malignancy suspected
|
PTH interpretation:
- ↑ or normal → Primary hyperparathyroidism
- ↓ → Malignancy / vitamin D excess / granulomatous disease
|
| 5️⃣ If Calcium Remains High |
- 💉 IV Zoledronic acid 4 mg
- Alternative: Pamidronate 60–90 mg IV
|
- Onset: 24–48 h
- Peak effect: 4–7 days
|
| 6️⃣ Severe / Refractory |
- Calcitonin (short-term effect)
- Denosumab if bisphosphonate-resistant
- Dialysis if renal failure or life-threatening hypercalcaemia
|
Usually managed with endocrine or oncology input.
|
| 7️⃣ Definitive Treatment |
Treat the underlying cause.
|
- Parathyroidectomy for primary hyperparathyroidism
- Oncology management for malignancy
- Steroids for sarcoidosis or lymphoma
|
🎓 Exam Tips – Hypercalcaemia
- 👉 Primary hyperparathyroidism is the most common cause of hypercalcaemia in the community.
- 👉 Malignancy is the most common cause of severe hypercalcaemia in hospital.
- 👉 Always check PTH first when investigating hypercalcaemia.
- 👉 The ECG change classically associated with hypercalcaemia is short QT interval.
- 👉 IV saline hydration is the first-line treatment before giving bisphosphonates.
- 👉 Hypercalcaemia symptoms are remembered by the phrase:
"Bones, Stones, Groans, and Psychiatric Overtones".